BBOT logo

BBOTBridgeBio Oncology Therapeutics Inc.

$8.27
$0.28
(3.27%)
Today
Closed $8.27
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 12
Mkt Cap$684.92M
Vol135,439.00
News
all
press releases
What is HC Wainwright's Forecast for BBOT FY2026 Earnings?
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT - Free Report) - HC Wainwright cut their FY2026 earnings per share (EPS) estimates for shares of BridgeBio Oncology Therapeutics in a report issued...
MarketBeat
News Placeholder
More News
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 52-Week Low - Here's What Happened
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sets New 52-Week Low - Here's Why...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Up 4.9% - Here's What Happened
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Up 4.9% - Still a Buy...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 5.8% - Should You Sell?
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 5.8% - What's Next...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sees Large Volume Increase - Still a Buy?
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sees Strong Trading Volume - Time to Buy...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 6.8% - What's Next?
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 6.8% - Time to Sell...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 12-Month Low - Should You Sell?
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 12-Month Low - Here's What Happened...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 1.3% - Should You Sell?
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 1.3% - Should You Sell...
MarketBeat
News Placeholder
BridgeBio Oncology (BBOT) Spotlights Next-Gen RAS Pipeline, $425M Cash Runway Into 2028
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) used a presentation at Leerink Partners' Global Healthcare Conference to outline its strategy around next-generation RAS therapeutics, highlighting three...
MarketBeat
News Placeholder
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Issues Quarterly Earnings Results
BridgeBio Oncology Therapeutics (NASDAQ:BBOT - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) EPS for the quarter, topping analysts' consensus...
MarketBeat
<
1
2
...
>